It influences on the white coat effect and the cardiac frequency of the antihypertensive medicaments used in an urban center of health;Influencia sobre el efecto de bata blanca y la frecuencia cardiaca de los fármacos antihipertensivos usados en un centro de salud urbano

Revista de Investigacion Clinica

Volumn 55, Issue 4, 2003, Pages 429-437

  Villalba Alcalá, Francisco ^a,b   Lapetra Peralta, José ^a   Espino Montoro, Antonio ^a   González Fernández, Ma Carmen ^a   López Chozas, José Manuel ^a  

^a HOSPITAL DE LA MERCED   (Spain)

^b Hospital de la Merced ^*  (Spain)

Author keywords

Ambulatory blood pressure monitoring; Antihypertensive; Antihypertensive pharmacs; Cardiac frequency; Urban center of health; White coat effect

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONSULTATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG USE; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; URBAN POPULATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URBAN HEALTH SERVICES;

EID: 0345329505     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hoegholm A, Kristensen KS, Madsen NH, Svendsen TL. White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients. Am J Hipertens 1992; 5: 64-70.
2. Khoury S, Yarows SA, O'Brien TK, Sowers JR. Ambulatory blood pressure monitoring in a non academic setting. Effects of age and sex. Am J Hypertens 1992; 5: 616-23.
3. Weber MA, Neutel JM, Smith DHG, Graettinger WF. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90: 2291-8.
4. Pickering TG, James GD, Boddie Ch, Harshfield GA, Blank S, Laragh J. How common is white coat hypertension? JAMA 1988; 259: 225-8.
5. Myers MG, Reeves RA. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991; 4: 844-9.
6. Enstrom I, Thulin T, Lindholm L. How good are standardized blood pressure recordings for diagnosing hypertension? A comparison between office and ambulatory blood pressure. J Hypertens 1991; 9: 561-6.
7. Ministerio de Sanidad y Consumo. Control de la Hipertensión Arterial en España, Madrid: IDEPSA 1996.
8. The sixth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413-46.
9. Guidelines for the management of mild hypertension memorandum from a World Health Organization/International Society of Hypertension Meeting, Guidelines Sub-Committee. J Hypertens 1993; 11: 905-18.
10. Public Policy Committee. American Society of Hypertension recommendations for clinical blood pressure measurements. Am J Hypertens 1993; 94: 181-7.
11. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society Protocol. J Hypertens 1991; 9: 573-4.
12. Mayoral E, Diez A, Lapetra J, Santos JM, García F, Rodríguez-Morcillo A. Validación del sistema de monitorización ambulatoria de presión arterial modelo SpaceLabs 90207. Med Clin 1994; 103: 326-30.
13. O'Brien E, Petrie J, Littler W, De Suite M, Padfield PL, Altman DG, et al. The British Hypertension Society Protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11: 43-62.
14. Consensus document on non-invasive ambulatory blood pressure monitoring. J Hypertens 1990; 8(Suppl. 6): 135-40.
15. O'Brien E, Coats A, Owens P, Petrie J, Padfiel PL, Littler W, et al. Use and interpretation of ambulatory blood pressure monitoring recommendations of the British Hypertension Society. Br Med J 2000; 320: 1128-34.
16. Mora-Macia J, Agraz PI, Ocon PJ, Barceló P. Estudio del intervalo clínicamente útil para monitorizar la presión arterial ambulatoria. Med Clin (Barc) 1997; 108: 248-53.
17. Gert A, Van M, Task FI. Methodological aspects. Frequency of measurements blood. Press Monit 1999; 4: 279-93.
18. National High Blood Pressure Education Program Working Group Report on ambulatory blood pressure monitoring. Arch Intern Med 1990; 150: 2270-80.
19. Pickering TG. Blood pressure measurement and detection of hypertension. Lancet 1994; 344: 31-5.
20. Uzu T, Kimura G. Diuretics and circadian rhythm of blood pressure. J Clin Hypertens (Greenwich) 2000; 2: 273-8.
21. Pickering TG, James GD, Boddie Ch, Harshfield GA, Blank S, Laragh J. How common is white coat hypertension? JAMA 1988; 259: 225-8.
22. Mayoral E, Lapetra J, Santos JM, López A, Ruiz J, Cayuela A. El efecto de bata blanca en atención primaria. Análisis en la hipertensión arterial de nuevo diagnóstico. Med Clin (Barc) 1997; 108: 485-9.
23. Veerman DP, Van Montfrans GA. Nurse-measured of ambulatory blood pressure in routine hypertension care. J Hypertens 1993; 11: 287-92.
24. De la Figuera M. HTA en atención primaria. Protocolo 1999/2. Formación Médica Continuada en Aten Primaria 1999; 6: 1-36.
25. Siegel D, López J. Tendencias en el uso de antihipertensivos en los Estados Unidos. ¿Han modificado los hábitos de prescripción las recomendaciones del V Comité Nacional de 1993? JAMA 1997; 278: 1745-8.
26. Soumerai SB, Mc Laughlin TJ, Spiegelman E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-bloquers in elderly survivors of acute myocardial infarction. JAMA 1997; 277: 115-21.
27. Collins R, Peto R, McMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
28. Kaplan MN, Gifford RW. Choice of initial therapy for hypertension. JAMA 1996; 275: 1577-80.
29. Roca-Cusachs A, Rodicio JL. Antagonistas del calcio y su impacto sobre el riesgo coronario. Med Clin (Barc) 1996; 107: 533-4.
30. Ad hoc Subcommittee of the Liaison Committee of the World Health Organization and the International Society of Hypertension. Effects of calcium antagonists on the risk of coronary heart disease, cancer and bleeding. J Hypertens 1997; 15: 105-15.
31. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, et al. The risk of myocardial infarction associated with antyhipertensive drug therapies. JAMA 1995; 274: 620-5.
32. Pahor M, Guralnik JM, Corte MC, Foley DJ, Carbonien P, Havlik RJ, et al. Long-term survival and use of antyhipertensive medications in older persons. J Am Geriatr Soc 1995;, 43: 1191-7.
33. Córdoba R. Reacciones adversas a los fármacos antihipertensivos. Aten Primaria 1996; 6: 420-4.
34. Prieto M, de Abajo FJ, Montero D, Martín-Serrano G, Madurga M, Palop R. Uso de antihipertensivos en España, 1985-1995. Med Clin (Barc) 1998; 110: 247-53.
35. Myers MG, Oh PI, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive in the community. Am J Hypertens 1995; 8: 591-7.
36. Pozuelo G, Molina L, Buitrago F. Confirmación diagnóstica de hipertensión arterial ligera mediante monitorización ambulatoria. Aten Primaria 1993; 12: 197-200.
37. Mancia G, Grasi G, Pomidossi G, Gregorini L, Bertinieri G, Parati G, et al. Effects of blood pressure measurements by de doctor on patient's blood pressure and heart rate. Lancet 1983; 2: 695-8.
38. Siegel WC, Blumenthal JA, Divine GW. Physiological, psychological, and behavioral factors and white coat hypertension. Hypertens 1990; 16: 140-6.
39. Lerman CE, Brody DS, Hui T, Lazaro C, Smith DG, Bum MJ. The white-coat hypertension response prevalence and predictors. J Gen Intern Med 1989; 4: 226-31.
40. Macdonald MB. Laing GP, Wilson MP, Wilson TW. Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ 1999; 161: 265-9.